Healthcare -
Biotechnology - NASDAQ - US
$ 5.33
0.947 %
$ 237 M
Market Cap
-1.7
P/E
VSTM - COST OF REVENUE
Cost of Revenue VSTM - Verastem, Inc.
62 K
LAST VALUE
-45.14%
2 YEAR CAGR
-17.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR